Prenatal Antidepressants May Increase Lung Problems in Babies

January 30, 2014 | Crandall & Pera Law
Prenatal Antidepressants May Increase Lung Problems in Babies

Antidepressants taken during pregnancy, especially after 33 weeks, may increase the risk for both immediate and long-term lung problems in babies, according to a recent CBS News article.

The breathing problems, called persistent pulmonary hypertension, occur when high blood pressure in the lungs prevents oxygen from moving to the lungs through the rest of the body. Symptoms include rapid breathing, rapid heart rate, difficulty breathing and a blue tint to the skin.

Canadian researchers pulled seven studies that looked at breathing difficulties in newborns associated with antidepressant use. The studies that met the researchers' criteria looked at selective serotonin reuptake inhibitors antidepressants, or SSRIs, a commonly-prescribed class of the medication which includes drugs like Lexapro, Prozac, Zoloft and Paxil.

Researchers estimate the overall risk may still remain low, occurring in about 2.9 to 3.5 births per 1,000, but this might be the very first review looking at this breathing risk in children of antidepressant-takers.

"Decisions on treatment needs to be personalized," said study author Dr. Sophie Grigoriadis. "Women need to make informed decisions by taking in all the risks of depression and its treatments." Read the full article here:

Antidepressants during pregnancy may raise risk for lung problems in babies

Women who are taking anti-depressants, and are pregnant or considering having children, should read this article.

If you or anyone in your family has suffered serious side effects or damages from a medication error you should seek legal investigation immediately. Crandall & Pera Law is available to help answer your questions and guide you in determining your next steps.